As of 2026-03-12, the Relative Valuation of Abbott Laboratories (ABT) is 128.00 USD. This relative valuation is based on P/E multiples. With the latest stock price at 110.09 USD, the upside of Abbott Laboratories based on Relative Valuation is 16.3%.
The range of the Relative Valuation is 113.76 - 146.40 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.3x - 36.5x | 33.2x |
| Forward P/E multiples | 24.7x - 30.8x | 27.6x |
| Fair Price | 113.76 - 146.40 | 128.00 |
| Upside | 3.3% - 33.0% | 16.3% |
| Date | P/E |
| 2026-03-11 | 29.34 |
| 2026-03-10 | 29.47 |
| 2026-03-09 | 30.03 |
| 2026-03-06 | 29.20 |
| 2026-03-05 | 29.60 |
| 2026-03-04 | 30.15 |
| 2026-03-03 | 30.28 |
| 2026-03-02 | 30.42 |
| 2026-02-27 | 31.01 |
| 2026-02-26 | 30.99 |
| 2026-02-25 | 30.59 |
| 2026-02-24 | 30.54 |
| 2026-02-23 | 30.73 |
| 2026-02-20 | 29.91 |
| 2026-02-19 | 29.90 |
| 2026-02-18 | 30.20 |
| 2026-02-17 | 29.92 |
| 2026-02-13 | 30.03 |
| 2026-02-12 | 29.71 |
| 2026-02-11 | 30.28 |
| 2026-02-10 | 29.93 |
| 2026-02-09 | 29.60 |
| 2026-02-06 | 29.54 |
| 2026-02-05 | 29.07 |
| 2026-02-04 | 28.84 |
| 2026-02-03 | 29.06 |
| 2026-02-02 | 29.16 |
| 2026-01-30 | 29.13 |
| 2026-01-29 | 28.28 |
| 2026-01-28 | 28.27 |
| 2026-01-27 | 28.86 |
| 2026-01-26 | 28.99 |
| 2026-01-23 | 28.63 |
| 2026-01-22 | 28.95 |
| 2026-01-21 | 32.18 |
| 2026-01-20 | 32.29 |
| 2026-01-16 | 32.45 |
| 2026-01-15 | 32.92 |
| 2026-01-14 | 33.32 |
| 2026-01-13 | 33.13 |
| 2026-01-12 | 33.22 |
| 2026-01-09 | 33.56 |
| 2026-01-08 | 33.63 |
| 2026-01-07 | 33.86 |
| 2026-01-06 | 34.06 |
| 2026-01-05 | 33.70 |
| 2026-01-02 | 33.10 |
| 2025-12-31 | 33.39 |
| 2025-12-30 | 33.52 |
| 2025-12-29 | 33.20 |